Karuna Therapeutics, Inc. Proceeds from Convertible Debt
Karuna Therapeutics, Inc. reported Proceeds from Convertible Debt of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2022-02-24
- Karuna Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- Karuna Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- Karuna Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2019-06-30 was $1.56M, a 60.90% decline year-over-year.
- Karuna Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2019-03-31 was $1.56M, a 47.87% decline year-over-year.
- Karuna Therapeutics, Inc. proceeds from convertible debt for fiscal 2021 was $0.00.
- Karuna Therapeutics, Inc. proceeds from convertible debt for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Karuna Therapeutics, Inc. proceeds from convertible debt for fiscal 2019 was $3.13M, a 73.26% decline from fiscal 2018.
- Karuna Therapeutics, Inc. proceeds from convertible debt for fiscal 2018 was $11.70M.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-24 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-02-24 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $1.56M derived: sum of 3 quarters · filed 2022-02-24 | $3.13M 10-K · filed 2022-02-24 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.56M derived: sum of 2 quarters · filed 2020-11-05 | $3.13M 10-Q · filed 2020-11-05 | $5.83M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $3.13M 10-Q · filed 2020-08-05 | $5.83M derived: sum of 3 quarters · filed 2021-02-25 | $7.83M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $1.56M 10-Q · filed 2020-05-07 | $4.26M derived: sum of 2 quarters · filed 2021-02-25 | $6.26M derived: sum of 3 quarters · filed 2021-02-25 | $10.26M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $4.70M derived: sum of 2 quarters · filed 2021-02-25 | $8.70M derived: sum of 3 quarters · filed 2021-02-25 | $11.70M 10-K · filed 2021-02-25 |
| 2018-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $6.00M derived: sum of 2 quarters · filed 2019-11-07 | $9.00M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $4.00M 10-Q · filed 2019-08-08 | $7.00M 10-Q · filed 2019-11-07 | ||
| 2018-03-31 | $3.00M 10-Q · filed 2019-08-08 |